© 1995 Oxford University Press
research-article |
Hepatocarcinogenicity of chlordane in B6C3F1 and B6D2F1 male mice: evidence for regression in B6C3F1 mice and carcinogenesis independent of ras proto-oncogene activation
1Department of Microbiology, Pathology and Parasitology, College of Veterinary Medicine, North Carolina State University Raleigh, NC 27606
2Environmental Carcinogenesis Program Research Triangle Park, NC 27709, USA
3Environmental Biology and Medicine Program, National Institute of Environmental Health Sciences Research Triangle Park, NC 27709, USA
4Experimental Pathology Laboratories Research Triangle Park, NC 27709, USA
5To whom correspondence should be addressed
Logistic regression analysis of age-specific prevalences for neoplastic and non-neoplastic liver lesions was used to examine treatment responses for B6C3F1 and B6D2F1 male mice continuously exposed to chlordane (55 p.p.m.) and to determine whether neoplasms were dependent on continuous exposure in the B6C3F1 mice. In order to determine if ras oncogene activation plays a role in the carcinogenicity of chlordane and whether the activation is dependent on genetic background, liver tumors from chlordane-treated B6C3F1 and B6D2F1 mice were analyzed for the presence of activating mutations in the ras oncogene. The overall liver tumor prevalence at terminal killing was nearly 100% for both strains; however, the age-specific prevalence increased more rapidly in B6C3F1 mice than in B6D2F1 mice. Tumor-bearing B6C3F1 mice had an average of two more tumors per liver than B6D2F1 mice at their respective terminal killings (5.4 versus 3.3). When chlordane exposure was discontinued for a group of B6C3F1 mice (‘stop’ group) at 491 days of age, overall tumor multiplicity significantly decreased by 30% from an average of 4.4 per tumor-bearing-animal at 525 days to 3.1 at terminal killing (568 days). Over the same time period the prevalence of hepatocellular carcinomas significantly decreased from 80 to 54% and adenomas from 100 to 93% by terminal killing in B6C3F1 ‘stop-group’ mice. Chlordane induced diffuse hepatocellular centrilobular hypertrophy, frequent multinucleate hepatocytes, toxic change and hepatoproliferative lesions composed predominantly of acidophilic hepatocytes in nearly 100% of both the B6C3F1 and B6D2F1 mice. The development of histological evidence of toxicity closely paralleled the temporal development of hepatocellular neoplasia and decreased in severity when the tumor burden was maximal. No H- or K-ras mutations were detected in the chlordane-induced hepatocellular tumors in B6C3F1 mice (15 adenomas and 15 carcinomas) or B6D2F1 mice (10 adenomas and 10 carcinomas). In conclusion, chlordane induced liver tumors in both B6C3F1 and B6D2F1 male mice by mechanisms independent of ras oncogene activation and 30% of both benign and malignant liver tumors in the B6C3F1 mice regressed after exposure was discontinued.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Hayashi, E. Fujii, A. Kato, K. Kimura, K. Mizoguchi, M. Suzuki, T. Sugimoto, H. Takanashi, Z. Itoh, S. Omura, et al. Characterization of Multinuclear Hepatocytes Induced in Rats by Mitemcinal (GM-611), an Erythromycin Derivative Toxicol Pathol, October 1, 2008; 36(6): 858 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Jackson, I. Lea, A. Rashid, S. D. Peddada, and J. K. Dunnick Genetic Alterations in Cancer Knowledge System: Analysis of Gene Mutations in Mouse and Human Liver and Lung Tumors Toxicol. Sci., April 1, 2006; 90(2): 400 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Malarkey, J. S. Parker, C. A. Turman, A. M. Scott, R. S. Paules, J. Collins, and R. R. Maronpot Microarray Data Analysis of Mouse Neoplasia Toxicol Pathol, January 1, 2005; 33(1): 127 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takahashi, G. E. Dinse, J. F. Foley, J. F. Hardisty, and R. R. Maronpot Comparative Prevalence, Multiplicity, and Progression of Spontaneous and Vinyl Carbamate-Induced Liver Lesions in Five Strains of Male Mice Toxicol Pathol, August 1, 2002; 30(5): 599 - 605. [Abstract] [PDF]
|
|
|
|
 |
|
 J. G. Christensen, E. H. Romach, L. N. Healy, A. J. Gonzales, S. P. Anderson, D. E. Malarkey, J. C. Corton, T. R. Fox, R. C. Cattley, and T. L. Goldsworthy Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice Carcinogenesis, August 1, 1999; 20(8): 1583 - 1590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-H. L. Hong, T. R. Devereux, J. H. Roycroft, G. A. Boorman, and R. C. Sills Frequency of ras Mutations in Liver Neoplasms from B6C3FX Mice Exposed to Tetrafluoroethylene for Two Years Toxicol Pathol, September 1, 1998; 26(5): 646 - 650. [Abstract] [PDF]
|
|
|
|
 |
|
 W H Butler, K L Gabriel, T G Osimitz, and F J Preiss Oncogenicity studies of piperonyl butoxide in rats and mice Human and Experimental Toxicology, June 1, 1998; 17(6): 323 - 330. [Abstract] [PDF]
|
|
|
|
|
|
R.R. Maronpot and G.A. Boorman The Contribution of the Mouse in Hazard Identification Studies Toxicol Pathol, November 1, 1996; 24(6): 726 - 731. [Abstract] [PDF]
|
|
|
|
|
|
W.H. Butler Letter To the Editor Toxicol Pathol, September 1, 1996; 24(5): 644 - 644. [PDF]
|
|
|
|
|
|
W.H. Butler A Review of the Hepatic Tumors Related to Mixed-Function Oxidase Induction in the Mouse Toxicol Pathol, July 1, 1996; 24(4): 484 - 492. [Abstract] [PDF]
|
|